Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Concerns about the effects of gender-affirming hormonal treatment (HT) on bone mineral density (BMD) in transgender people exist, particularly regarding the decrease in estrogen concentrations in transmen. Although it is known that HT is safe for BMD in the short term, long-term follow-up studies are lacking. Therefore this study aimed to investigate the change in BMD during the first 10 years of HT, to determine whether HT is safe and if assessing BMD during HT is necessary. A follow-up study was performed in adult transgender people receiving HT at the VU University Medical Center Amsterdam between 1998 and 2016. People were included if they were HT naive and had a dual-energy X-ray absorptiometry (DXA) scan at the start of HT. Follow-up DXA scans performed after 2, 5, and/or 10 years of HT were used for analyses. The course of BMD of the lumbar spine during the first 10 years of HT was analyzed using multilevel analyses. A total of 711 transwomen (median age 35 years; IQR, 26 to 46 years) and 543 transmen (median age 25 years; IQR, 21 to 34 years) were included. Prior to the start of HT, 21.9% of transwomen and 4.3% of transmen had low BMD for age (Z-score < –2.0). In transwomen lumbar spine BMD did not change (+0.006; 95% CI, –0.005 to +0.017), but lumbar spine Z-score increased by +0.22 (95% CI, +0.12 to +0.32) after 10 years of HT. Also in transmen lumbar spine BMD did not change (+0.008; 95% CI, –0.004 to +0.019), but lumbar spine Z-score increased by +0.34 (95% CI, +0.23 to +0.45) after 10 years of HT. This study showed that HT does not have negative effects on BMD, indicating that regularly assessing BMD during HT is not necessary. However, a high percentage of low BMD was found prior to HT, especially in transwomen. Therefore, evaluation of BMD before start of HT may be considered. © 2018 The Authors. Journal of Bone and Mineral Research Published by Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hembree, W. C., Cohen-Kettenis, P. T., Gooren, L., Hannema, S. E., Meyer, W. J., Murad, M. H., Rosenthal, S. M., Safer, J. D., Tangpricha, V., & T’Sjoen, G. G. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01658 · Cited by 2,328 · cited 2×
“The results of this study support the statements of the Endocrine Society Guideline(30) that clinicians should assess BMD only when risk factors for osteoporosis exists, and especially in those who stop HT after gonadectomy.”
ResultEstrogens and androgens in skeletal physiology and pathophysiology
Almeida, M., Laurent, M. R., Dubois, V., Claessens, F., O'Brien, C. A., Bouillon, R., Vanderschueren, D., & Manolagas, S. C. (2017) · Physiological Reviews · doi:10.1152/physrev.00033.2015 · Cited by 860
Katznelson, L., Finkelstein, J. S., Schoenfeld, D. A., Rosenthal, D. I., Anderson, E. J., & Klibanski, A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954042 · Cited by 791 · cited 12×
“In transwomen with higher estradiol concentrations during HT an increase in LS BMD was found, whereas low estradiol concentrations were associated with a decrease in LS BMD. Testosterone concentrations were suppressed in the majority of the population and were not associated with the change in LS BMD. LH concentration…”
BackgroundInfluentialFalahati-Nini, A., Riggs, B. L., Atkinson, E. J., O’Fallon, W. M., Eastell, R., & Khosla, S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10942 · Cited by 757 · cited 1×
“However, more recent studies indicated that the effects of hypogonadism on bone in men are mainly due to estrogen instead of testosterone deficiency.((7,8)) In both hypogonadal men and women, treatment with sex hormones increases BMD.”
BackgroundGonadal steroid–dependent effects on bone turnover and bone mineral density in men
Finkelstein, J. S., Lee, H., Leder, B. Z., Burnett-Bowie, S.-A. M., Goldstein, D. W., Hahn, C. W., Hirsch, S. C., Linker, A., Perros, N., Servais, A. B., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci84137 · Cited by 198 · cited 2×
“This is also in line with earlier studies who reported that BMD was better correlated with estradiol concentrations than testosterone concentrations.((7,29))”
BackgroundResultVan Caenegem, E., Wierckx, K., Taes, Y., Schreiner, T., Vandewalle, S., Toye, K., Lapauw, B., Kaufman, J.-M., & T'Sjoen, G. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0586 · Cited by 160 · cited 1×
“08) Creatinine (mmol/L), mean SD 76 (11) 72 (11) 66 (10) 78 (11) AF (U/L), mean SD 71 (19) 67 (23) 70 (22) 78 (21) SHBG (nmol/L), median (IQR) 35 (26–46) 43 (29–59) 51 (31–81) 28 (20–36)”
Body composition, volumetric and areal bone parameters in male-to-female transsexual persons
Lapauw, B., Taes, Y., Simoens, S., Van Caenegem, E., Weyers, S., Goemaere, S., Toye, K., Kaufman, J.-M., & T'Sjoen, G. G. (2008) · Bone · doi:10.1016/j.bone.2008.09.001 · Cited by 131
Van Caenegem, E., Wierckx, K., Taes, Y., Schreiner, T., Vandewalle, S., Toye, K., Kaufman, J.-M., & T’Sjoen, G. (2015) · Osteoporosis International · doi:10.1007/s00198-014-2805-3 · Cited by 116
Cross-sex pattern of bone mineral density in early onset gender identity disorder
Haraldsen, I. R., Haug, E., Falch, J., Egeland, T., & Opjordsmoen, S. (2007) · Hormones and Behavior · doi:10.1016/j.yhbeh.2007.05.012 · Cited by 113 · cited 1×
“Even prior to HT differences are observed: transwomen had lower BMD compared with control men,((12,26)) whereas transmen had higher((12)) or similar((25)) BMD than control women, indicating that the difference in BMD after long-term HT might already be present at baseline.”
BackgroundMueller, A., Zollver, H., Kronawitter, D., Oppelt, P. G., Claassen, T., Hoffmann, I., Beckmann, M. W., & Dittrich, R. (2010) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0030-1255074 · Cited by 93
Cited by
Hilton, E. N., & Lundberg, T. R. (2021) · Sports Medicine · doi:10.1007/s40279-020-01389-3 · Cited by 236
Harper, J., O'Donnell, E., Sorouri Khorashad, B., McDermott, H., & Witcomb, G. L. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-103106 · Cited by 206
“14 However, studies in non-athletic transwomen undergoing GAHT also report changes in lean body mass (LBM), 15 muscle cross-sectional area (CSA), 16 muscular strength 17 and haemoglobin (Hgb) 18 and/ or haematocrit (HCT).”
Auer, M. K., Paizoni, L., Hofbauer, L. C., Rauner, M., Chen, Y., Schmidt, H., Huebner, A., Bidlingmaier, M., & Reisch, N. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2020.105734 · Cited by 33
“The anabolic effect of testosterone in women has for example been demonstrated in transgender men receiving testosterone treatment (35, 36), resulting in an increase in BMD despite inducing amenorrhea, indicating that peripheral aromatization may be sufficient to sustain bone health.”
Metadata
- Authors
- Wiepjes, C. M., de Jongh, R. T., de Blok, C. J., Vlot, M. C., Lips, P., Twisk, J. W., & den Heijer, M.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-07
- Volume
- 34
- Issue
- 3
- Pages
- 447-454
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2903698091
- Cited by
- 136
- References
- 10
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen. https://app.cochat.ai/papers/10.1002/jbmr.3612
- The paper
- Wiepjes, C. M., de Jongh, R. T., de Blok, C. J., Vlot, M. C., Lips, P., Twisk, J. W., & den Heijer, M. (2019). Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.3612
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.